BackGSK Plc Overview

GSK Plc Intangible Assets

Latest intangible assets for GSK: $25B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$25.34B

Peer trimmed avg / median

Loading

GSK Plc Intangible Assets History

Loading

GSK Plc vs. peers: Intangible Assets Comparison

Loading

GSK Plc Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GSK Plc (GSK) FAQ

GSK Plc's intangible assets stands at $25B as of September 2026. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether GSK Plc's intangible assets is expanding or contracting. Sustained growth in intangible assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how GSK Plc's intangible assets evolved across reporting periods, while the comparison chart places GSK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, intangible assets is commonly used to spot outliers. GSK Plc's reading of $25B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.